AU2008315740A1 - Process for preparing O-desmethylvenlafaxine - Google Patents

Process for preparing O-desmethylvenlafaxine Download PDF

Info

Publication number
AU2008315740A1
AU2008315740A1 AU2008315740A AU2008315740A AU2008315740A1 AU 2008315740 A1 AU2008315740 A1 AU 2008315740A1 AU 2008315740 A AU2008315740 A AU 2008315740A AU 2008315740 A AU2008315740 A AU 2008315740A AU 2008315740 A1 AU2008315740 A1 AU 2008315740A1
Authority
AU
Australia
Prior art keywords
process according
odv
thiol
disorder
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008315740A
Other languages
English (en)
Inventor
Vinayak G. Gore
Vikas S. Kulkarni
M. Patil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Original Assignee
Generics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd filed Critical Generics UK Ltd
Publication of AU2008315740A1 publication Critical patent/AU2008315740A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2008315740A 2007-10-26 2008-10-18 Process for preparing O-desmethylvenlafaxine Abandoned AU2008315740A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2122MU2007 2007-10-26
IN2122/MUM/2007 2007-10-26
PCT/GB2008/050962 WO2009053731A1 (en) 2007-10-26 2008-10-18 Process for preparing o-desmethylvenlafaxine

Publications (1)

Publication Number Publication Date
AU2008315740A1 true AU2008315740A1 (en) 2009-04-30

Family

ID=40139287

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008315740A Abandoned AU2008315740A1 (en) 2007-10-26 2008-10-18 Process for preparing O-desmethylvenlafaxine

Country Status (8)

Country Link
US (1) US20110118357A1 (enExample)
EP (1) EP2200968A1 (enExample)
JP (1) JP2011500777A (enExample)
CN (1) CN101952240A (enExample)
AU (1) AU2008315740A1 (enExample)
CA (1) CA2703647A1 (enExample)
NZ (1) NZ585368A (enExample)
WO (1) WO2009053731A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ303249B6 (cs) 2010-04-06 2012-06-20 Zentiva, K.S. Zpusob výroby 4-(2-(substituovaných)-1-(1-hydroxycyklohexyl)ethyl)fenolu O-demethylací jejich methyletheru pomocí nepáchnoucích aromatických thiolu
EP2394976A1 (en) 2010-06-11 2011-12-14 LEK Pharmaceuticals d.d. Process for demethylating aromatic methyl ethers using 3-mercaptopropionic acid
JP6751200B2 (ja) * 2017-02-09 2020-09-02 アール エル ファインケム プライベート リミテッド １−［２−（ジメチルアミノ）−１−（４−ヒドロキシフェニル）エチル］−シクロヘキサノール及びその塩の製造方法
CN106928073A (zh) * 2017-03-27 2017-07-07 石家庄度恩医药科技有限公司 一种去甲文拉法辛的制备方法
CN106995376A (zh) * 2017-04-21 2017-08-01 上海华源医药科技发展有限公司 一种去甲文拉法辛的工业化生产工艺
CN109665966A (zh) * 2018-11-01 2019-04-23 山东蒲济医药科技有限公司 一种琥珀酸去甲文拉法辛化合物的制备方法
CN114478271B (zh) * 2021-12-13 2024-05-31 植恩生物技术股份有限公司 琥珀酸去甲文拉法辛制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6197828B1 (en) 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
ES2305606T3 (es) 1999-04-06 2008-11-01 Sepracor Inc. Succinato de o-desmetilvenlafaxina.
WO2000076955A1 (en) 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
ATE369330T1 (de) 2001-02-12 2007-08-15 Wyeth Corp O-desmethyl-venlafaxine succinat salz
UA80543C2 (en) * 2001-12-04 2007-10-10 Wyeth Corp Method for the preparation of o-desmethylvenlafaxine
RU2004139075A (ru) * 2002-06-10 2005-06-27 Уайт (Us) Новые формиат 0-десметилвенлафаксина
WO2007071404A1 (en) * 2005-12-20 2007-06-28 Synthon B.V. Process for making desvenlafaxine
EP2007708A1 (en) * 2006-04-17 2008-12-31 Teva Pharmaceutical Industries Ltd Substantially pure o-desmethylvenlafaxine and processes for preparing it
MX2007016179A (es) * 2006-04-17 2008-03-11 Teva Pharma Formas cristalinas de o-desmetilvenlafaxina.
AR064987A1 (es) * 2007-01-22 2009-05-06 Medichem Sa Proceso mejorado para sintetizar desvenlafaxina como base libre y sales o solvatos de la misma

Also Published As

Publication number Publication date
JP2011500777A (ja) 2011-01-06
NZ585368A (en) 2012-07-27
US20110118357A1 (en) 2011-05-19
CN101952240A (zh) 2011-01-19
EP2200968A1 (en) 2010-06-30
CA2703647A1 (en) 2009-04-30
WO2009053731A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
AU2008315740A1 (en) Process for preparing O-desmethylvenlafaxine
US20080177110A1 (en) Processes for the synthesis of O-desmethylvenlafaxine
US7385076B2 (en) Process for the preparation of phenylcarbamates
CN103153942B (zh) 制备叔氨基醇化合物的方法
US8722920B2 (en) Process for obtaining 3, 3-diphenylpropylamines
US10106477B2 (en) Process for preparing 1,4-bis(ethoxymethyl)cyclohexane
JP2011500777A5 (enExample)
EP1697313A2 (en) Processes for the preparation of aminoalkyl phenylcarbamates
US20110004023A1 (en) Potassium Organotrifluoroborate Derivative and a Production Method Therefor
KR20070083814A (ko) （ｓ）－３－［（１－디메틸아미노）에틸］－페닐－ｎ－에틸－ｎ－메틸－카바메이트의 제조를 위한 효과적인 방법
CA2672808A1 (en) Process for the preparation of o-desmethyl venlafaxine
AU2010272377A1 (en) Process for the preparation of O-desmethyl venlafaxine and intermediate for use therein
EP2318354A1 (en) Process for the preparation of o-desmethylvenlafaxine
EP2785688B1 (en) A process for the manufacture of chiral catalysts and their salts
US8754261B2 (en) Process for the preparation of O-desmethyl-venlafaxine and salts thereof
EP2054373B1 (en) Improved process for the preparation of rivastigmine
ES2343050B1 (es) Procedimiento para la preparacion de desvenlafaxina y sus sales de adicion de acido farmaceuticamente aceptables.
WO2009034434A2 (en) An improved process for the preparation of o-desmethylvenlafaxine
KR100701743B1 (ko) 밤부테롤의 신규한 제조 방법
MXPA02005174A (es) Eteres de o-desmetil venlafaxina.
WO2006003220A1 (es) Procedimiento para la obtención de 2-amino-6-alquil-amino-4,5,6,7-tetrahidrobenzotiazoles
WO2009144517A1 (en) Process for the preparation of cyclohexanol derivatives
WO2008013994A2 (en) Processes for the synthesis of o-desmethylvenlafaxine

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application